Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (500)	6/12/2004 5:34:15 PM
From: scaram(o)uche	Respond to of 12215

I can't make heads or tails of NicOx stuff. They just go headlong down their path, pretending that lots of stuff just isn't out there. These are healthy individuals (volunteers). I'm not looking for much of an "efficacy" nod. Would love to be wrong, and it would certainly validate the observations of Golde et al. But..... there's lots more than the dead center hypothesis of Golde et al. where flurbie could still look great. And you do, of course, know that true efficacy results are due before the end of 1Q05?